Jemt T, Lekholm U
Brånemark Clinic, Public Dental Health Service, University of Gothenburg, Sweden.
Int J Oral Maxillofac Implants. 1995 May-Jun;10(3):303-11.
In a retrospective study, 150 patients with edentulous maxillae were selected for treatment with Brånemark implants. The patients were arranged into four different groups, based on jaw shape prior to implant placement. After second-stage surgery, they were provided with either fixed prostheses, removable overdentures followed by fixed prostheses after at least 1 year, or overdentures for the whole period. Patients were followed up for 5 years, with implant and prosthesis survival, annual visits, marginal bone loss, and complications recorded. Results of the study indicated that treatment outcome in edentulous maxillae might be predicted by careful presurgical evaluation of jaw shape. Five-year cumulative implant failure rates varied from 7.9% for patients considered to have enough bone to be provided with fixed prostheses immediately after second-stage surgery to 28.8% for those with severely resorbed jaws receiving an overdenture. The corresponding cumulative prosthesis failure rates were 3.0% and 18.9%, respectively. Patients provided with autogenous bone grafts compared favorably to the group presenting severely resorbed jaws and provided with overdentures, but showed a compromised result compared to the group with the least resorption. Failure of implant treatment correlated significantly with bone quality and ratio of 7-mm implants. All groups, except those treated with bone grafts, showed an average marginal bone level of 1.2 mm after 5 years, irrespective of type of prosthesis. The bone-grafted group showed a corresponding mean level of 2.3 mm after 5 years of function. Regarding clinical complications, a different pattern, mainly related to the type of prosthetic construction used, was observed between the groups. The number of visits clearly indicated that severely resorbed jaws provided with overdentures were the most demanding.
在一项回顾性研究中,选择了150例无牙上颌患者接受Brånemark种植体治疗。根据种植体植入前的颌骨形状,将患者分为四个不同的组。二期手术后,为他们提供固定义齿、可摘覆盖义齿(至少1年后再更换为固定义齿)或整个期间都使用覆盖义齿。对患者进行了5年的随访,记录种植体和义齿的存留情况、年度复诊情况、边缘骨吸收情况以及并发症。研究结果表明,通过仔细的术前颌骨形状评估,可以预测无牙上颌的治疗效果。5年累计种植体失败率从二期手术后被认为骨量充足可立即安装固定义齿的患者的7.9%到接受覆盖义齿的严重吸收颌骨患者的28.8%不等。相应的累计义齿失败率分别为3.0%和18.9%。接受自体骨移植的患者与严重吸收颌骨并使用覆盖义齿的组相比效果较好,但与吸收最少的组相比结果较差。种植治疗失败与骨质量和7毫米种植体的比例显著相关。除接受骨移植治疗的组外,所有组在5年后的平均边缘骨水平为1.2毫米,与义齿类型无关。骨移植组在功能5年后的相应平均水平为2.3毫米。关于临床并发症,各治疗组之间观察到不同的模式,主要与所使用的修复结构类型有关。复诊次数清楚地表明,使用覆盖义齿的严重吸收颌骨患者的需求最大。